The Innovation Institute Announces Deloitte as Sponsor and Collaborator for its Innovation Lab in Newport Beach

Published on:

Newport Beach, Calif.  – August 11, 2015 – The Innovation Institute today announced that Deloitte & Touche LLP has signed an agreement to become a sponsor and collaborator for The Institute’s Innovation Lab in Newport Beach, Calif.
 
The Institute, an independent for-profit corporation, facilitates innovation among physicians and employees across major health care organizations. Through its Innovation Lab, medical product and delivery ideas are vetted with the best ones receiving further development for introduction into the health care industry.
 
Deloitte will advise the lab in navigating the complexities of the U.S. and global health care systems, drawing upon research and reports from the Deloitte Center for Health Solutions.  The Innovation Lab in turn will facilitate collaboration among Deloitte, inventors and like-minded organizations to focus on implementing value- and evidence-based health care models.
 
“We will collaborate with the Lab to develop and adopt strategies and approaches that improve the effectiveness of our health care system,” said Kevin Wijayawickrama, principal, Deloitte & Touche. “We are pleased to have the opportunity to work with The Innovation Institute, whose values reflect those of Deloitte.”
 
The Innovation Institute President and Chief Executive Officer Joe Randolph said, “We look to Deloitte for their expertise as we embrace a care model that leverages emerging technologies to transform delivery.”
 
The Institute’s Innovation Lab Executive Vice President Larry Stofko said, “With Deloitte as a collaborator, we see a future of transformation through innovation that empowers patients and enhances provider capabilities.”
 
About The Innovation Institute
The Innovation Institute is an independent, for-profit LLC structured to cultivate innovative solutions to transform healthcare delivery. The Innovation Institute is owned by non-profit health systems. This collaborative taps into physicians, employees, and industry business partners to incubate and commercialize new medical products and ideas. Comprised of three distinct elements – an innovation lab, an investment fund, and a shared services group (Enterprise Development Group), The Institute strives to “do more, with less, for more people.” For more information, visit www.ii4change.com

Related Content

5 ways to let AI raise patient satisfaction, elevate provider performance
When life sciences met artificial intelligence
AdvaMed itemizes AI imperatives for ‘the entire healthcare ecosystem’
6 things high-achieving orgs do to wring real value from AI
A modest proposal to rally AI regulators around a simple game plan
4 points crucial to the nimble regulation of GenAI

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."